(XHE) SPDR S&P Health Care - Ratings and Ratios
Medical Devices, Health Care Equipment, Hospital Supplies
Description: XHE SPDR S&P Health Care
The SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that tracks the S&P Health Care Equipment Select Industry Index, focusing on the healthcare equipment segment within the US market. By employing a sampling strategy, the fund invests at least 80% of its assets in the securities that comprise the index, aiming to replicate its performance.
Key performance indicators (KPIs) for XHE include its ability to provide diversified exposure to the healthcare equipment industry, which is a significant sector within the US healthcare market. The funds underlying index is part of the S&P Total Market Index (S&P TMI), indicating its coverage of a broad spectrum of the market. With an AUM of $164.07M USD, XHE offers liquidity and tradability, making it an attractive option for investors seeking to capitalize on trends within the healthcare equipment sector.
From a trading perspective, analyzing XHEs price movements and trends can provide insights into its potential for future growth or decline. For instance, comparing its current price to its SMA20, SMA50, and SMA200 can indicate its short-term, medium-term, and long-term trends, respectively. Additionally, the Average True Range (ATR) can be used to gauge the funds volatility, helping investors to assess potential risks and opportunities.
To further evaluate XHEs investment potential, one could examine its sector allocation, top holdings, and historical performance relative to its benchmark index. This analysis can help investors understand the funds risk profile, potential for returns, and how it fits within their overall investment strategy. Moreover, considering the funds expense ratio, trading volume, and bid-ask spread can provide a more comprehensive view of its cost-effectiveness and liquidity.
Additional Sources for XHE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
XHE ETF Overview
Market Cap in USD | 159m |
Category | Health |
TER | 0.35% |
IPO / Inception | 2011-01-26 |
XHE ETF Ratings
Growth Rating | -47.0 |
Fundamental | - |
Dividend Rating | 38.6 |
Rel. Strength | -22.6 |
Analysts | - |
Fair Price Momentum | 63.69 USD |
Fair Price DCF | - |
XHE Dividends
Dividend Yield 12m | 0.06% |
Yield on Cost 5y | 0.05% |
Annual Growth 5y | 100.00% |
Payout Consistency | 45.5% |
Payout Ratio | % |
XHE Growth Ratios
Growth Correlation 3m | -52.6% |
Growth Correlation 12m | -60.6% |
Growth Correlation 5y | -76.6% |
CAGR 5y | -4.63% |
CAGR/Max DD 5y | -0.09 |
Sharpe Ratio 12m | 0.23 |
Alpha | -22.79 |
Beta | 0.714 |
Volatility | 22.96% |
Current Volume | 16.6k |
Average Volume 20d | 15.8k |
Stop Loss | 74.2 (-3%) |
As of August 02, 2025, the stock is trading at USD 76.48 with a total of 16,645 shares traded.
Over the past week, the price has changed by -4.03%, over one month by -6.34%, over three months by -3.13% and over the past year by -10.22%.
Probably not. Based on ValueRay´s Analyses, SPDR S&P Health Care (NYSE ARCA:XHE) is currently (August 2025) not a good stock to buy. It has a ValueRay Growth Rating of -47.04 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XHE is around 63.69 USD . This means that XHE is currently overvalued and has a potential downside of -16.72%.
SPDR S&P Health Care has no consensus analysts rating.
According to our own proprietary Forecast Model, XHE SPDR S&P Health Care will be worth about 73.5 in August 2026. The stock is currently trading at 76.48. This means that the stock has a potential downside of -3.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 73.5 | -3.9% |